This Article Full Text Full Text (PDF) All Versions of this Article: 47/5/881    most recent 01.HYP.0000216778.83626.39v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Schillaci, G. Articles by Mannarino, E. Search for Related Content PubMed PubMed Citation Articles by Schillaci, G. Articles by Mannarino, E. Pubmed/NCBI databases Medline Plus Health Information High Blood Pressure Metabolic Syndrome Related Collections Risk Factors Hypertrophy Glucose intolerance Clinical Studies

(Hypertension. 2006;47:881.)
© 2006 American Heart Association, Inc.

Original Articles

Different Impact of the Metabolic Syndrome on Left Ventricular Structure and Function in Hypertensive Men and Women

Giuseppe Schillaci; Matteo Pirro; Giacomo Pucci; Massimo R. Mannarino; Fabio Gemelli; Donatella Siepi; Gaetano Vaudo; Elmo Mannarino

From the Unit of Internal Medicine, Angiology and Arteriosclerosis, University of Perugia, Perugia, Italy.

Correspondence to Giuseppe Schillaci, Unit of Internal Medicine, Angiology and Arteriosclerosis, University of Perugia Medical School, Hospital "S. Maria della Misericordia", piazzale Menghini, 1, 06132 Perugia, Italy. E-mail skill{at}unipg.it

Metabolic syndrome (MS) is increasingly recognized as an important cardiovascular risk factor in hypertension, but its influence on left ventricular (LV) mass and function in the 2 genders has not been specifically addressed. Among 618 nondiabetic, untreated hypertensive subjects, echocardiographically detected LV mass was significantly greater in subjects with MS. A significant interaction was observed between sex and the MS (P<0.003 for the multiplicative interaction term). Compared with women without the MS, those with the syndrome had a 24% greater LV mass (49.5±12 versus 40.0±10 gxm^–2.7; P<0.001), whereas the difference was only 9% in men (50.3±12 versus 46.1±10 gxm^–2.7; P=0.003). A greater prevalence of LV hypertrophy was found in women (37% versus 14%; P<0.001) but not in men (39% versus 29%; P=0.09) with the MS. After adjustment for the effect of age, body mass index, 24-hour systolic blood pressure, and several confounders, the MS was independently associated with a greater LV mass index in women (regression coefficient, 4.80; P<0.001) but not in men. Women with the MS also had a greater LV relative wall thickness (0.42±0.07 versus 0.39±0.07; P=0.004) and a depressed afterload-corrected midwall fractional shortening (94.0±12% versus 101.0±13%; P<0.001) than women without the syndrome, whereas no differences emerged in men. We conclude that, in untreated hypertension, MS has a different impact on LV hypertrophy and function in men and women. The effect of MS is more pronounced in women and is partly independent from the effect of several hemodynamic and nonhemodynamic determinants of LV mass.

Key Words: hypertrophy • remodeling • metabolism • gender • risk factors

This article has been cited by other articles:

				J Sundstrom, J Arnlov, K Stolare, and L Lind Blood pressure-independent relations of left ventricular geometry to the metabolic syndrome and insulin resistance: a population-based study Heart, July 1, 2008; 94(7): 874 - 878. [Abstract] [Full Text] [PDF]

				Authors/Task Force Members:, G. Mancia, G. De Backer, A. Dominiczak, R. Cifkova, R. Fagard, G. Germano, G. Grassi, A. M. Heagerty, S. E. Kjeldsen, et al. 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Eur. Heart J., June 11, 2007; (2007) ehm236v1. [Full Text] [PDF]

				G. Mancia, M. Bombelli, G. Corrao, R. Facchetti, F. Madotto, C. Giannattasio, F. Q. Trevano, G. Grassi, A. Zanchetti, and R. Sega Metabolic Syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) Study: Daily Life Blood Pressure, Cardiac Damage, and Prognosis Hypertension, January 1, 2007; 49(1): 40 - 47. [Abstract] [Full Text] [PDF]